NICE Provides Positive Guidance on electroCore's gammaCore Treatment for the Prevention and Acute Treatment of Migraine and Cluster Headache

BASKING RIDGE, New Jersey, April 1, 2016 -- (Healthcare Sales & Marketing Network) -- The UK's National Institute of Health and Care Excellence (NICE) has published guidance that electroCore's non-invasive vagus nerve stimulation treatment (gammaCore) for... Devices, Neurology, RegulatoryelectroCore, gammaCore, vagus nerve stimulation, migraine
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news